HLLY vs ZUMZ

HLLY presents a complex profile where strong defensive valuation metrics clash with poor operational execution. The Piotroski F-Score of 4/9 indicates stable but mediocre financial health, while the current price of $3.37 sits comfortably below the Graham Number ($3.69) but significantly above the growth-based Intrinsic Value ($1.12). While the company outperforms its sector in profitability and maintains a strong current ratio, a disastrous earnings track record (0/4 beats in the last year) and negative YoY EPS growth (-63.6%) create significant headwinds. The stock appears undervalued on a book and sales basis, but lacks the fundamental momentum to justify a bullish rating.

ZUMZ exhibits strong financial health with a Piotroski F-Score of 7/9, indicating a robust operational recovery. While earnings growth is impressive at 49.1% YoY and the PEG ratio of 0.96 suggests reasonable valuation relative to growth, the current price of $24.64 trades at a premium to both the Graham Number ($19.3) and the Intrinsic Value ($23.01). The outlook is tempered by extremely thin net profit margins (1.44%) and a bearish insider sentiment characterized by consistent selling.